JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Greiner, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Greiner, T.
Journal of Pharmacology And Experimental Therapeutics, Vol. 117, Issue 2, 228-231, 1956
Copyright © 1956 by American Society for Pharmacology and Experimental Therapeutics

THE EFFECT OF A VASOCONSTRICTIVE AGENT, METARAMINOL, ON HUMAN TOLERANCE TO ACCELERATION

Theodore Greiner 1

1 Aero Medical Laboratory, Wright Air Development Center, Air Research and Development Command, Wright Patterson Air Force Base, Ohio

Metaraminol in oral doses of 1 mgm. per kgm. increased tolerance to positive acceleration an average of 0.7 g-unit in 8 volunteers tested on the human centrifuge. This protection was far below that provided by the G-suit or by gradual induction of acceleration. Combination of metaraminol with either of these two systems provided no additional advantage.

Submitted on February 3, 1956






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1956 by the American Society for Pharmacology and Experimental Therapeutics.